Bangun Kosambi Sukses Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bangun Kosambi Sukses Tbk. trades at Rp3,500 (market cap 19.5T, 1.85M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Bangun Kosambi Sukses Tbk. is far larger — about 62.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Bangun Kosambi Sukses Tbk. is more actively traded (1.85M versus 963.6K). Which is the better fit depends on your goals.
| CBDK | DGNS | |
|---|---|---|
Market Cap | 19.5T | 310.75B |
Volume | 1.85M | 963.6K |
Lot | 18.52K | 9.64K |
Turnover | 6.5B | 217.67M |
Average Price | 3,512.14 | 225.89 |
Value | 6.5B | 217.67M |
Indicative Equilibrium Price | 3,500 | 226 |
Indicative Equilibrium Volume | 522 | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bangun Kosambi Sukses Tbk (the Company) was established based on Notarial Deed No. 01 of Djedjem Widjaja, S.H., M.H., dated 3 April 2000. The Company commenced its commercial operations in 2020. The Company is controlled by its immediate parent company, PT Pantai Indah Kapuk Dua Tbk, domiciled in Jakarta and its ultimate parent companies are PT Agung Sedayu and PT Tunas Mekar Jaya, domiciled in Jakarta.
Read more on CBDK →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →